Meeting for the External Peer Review of the U.S. Environmental Protection Agency's (U.S. EPA's) Draft "IRIS Toxicological Review of Perfluorodecanoic Acid and Related Salts" (PFDA)

Organized by: ERG
Date:

Day 1: Monday, July 10, 2023, 10:00 AM to 4:00 PM EDT
Day 2: Tuesday, July 11, 2023, 10:00 AM to 4:00 PM EDT
Day 3: Thursday, July 13, 2023, 11:30 AM to 2:15 PM EDT

Background

ERG, a contractor to EPA, is organizing an independent external peer review of the U.S. Environmental Protection Agency's (U.S. EPA's) draft "IRIS Toxicological Review of Perfluorodecanoic Acid and Salts" (PFDA). This draft document was prepared by the Center for Public Health and Environmental Assessment (CPHEA) within U.S. EPA's Office of Research and Development (ORD). For more information about IRIS assessments, visit U.S. EPA's IRIS Program website. For more information on the draft IRIS assessment of PFDA, visit U.S. EPA's PFDA assessment website.

The peer review meeting will take place virtually via Zoom on Monday, July 10, 2023, from 10:00 AM to 4:00 PM EDT; Tuesday, July 11, 2023, from 10:00 AM to 4:00 PM EDT; and Thursday, July 13, 2023, from 11:30 AM to 2:15 PM EDT. The meeting is open to anyone who would like to attend as an observer and will include a brief public comment period on the first day (July 10). Comments will be limited to 3 to 5 minutes (final limit TBD based on the number of commenters).

EPA requests that no individual or organization in any way contact the peer reviewers or make any offers or requests to them that are or appear to be linked to their participation in this peer review.

Draft PFDA Peer Review Meeting Agenda

The final agenda will be available on this webpage a few days prior to the meeting.

Technical Charge to Reviewers This link provides the latest (June 16, 2023) version of EPA's charge to reviewers, which updates the "Tier 1" description on page 1, modifies charge question 5(c), and moves charge question 5(d) to question 6(a).

U.S. EPA, 2023, HERO ID 11181055 This is the U.S. EPA reference cited in charge question 5(c).

EPA characterization of studies identified after public release of draft IRIS Toxicological Review of PFDA and Related Salts

Compilation of public comments received through the EPA docket

For More Information

For more information regarding registration or the peer review meeting, please contact laurie.waite@erg.com (subject line: PFDA Peer Review Meeting). If you have a disability that interferes with your ability to access the information on this page, please contact laurie.waite@erg.com (subject line: PFDA Peer Review Meeting) and let us know the nature of the accessibility problem and the preferred format in which you want to receive the information (e.g., ASCII, standard print, large print, etc.).

Online registration is now closed.